FRESENIUS KABI USA, LLC
LAKE ZURICH, IL

Limitations of Use: Because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses, reserve Morphine Sulfate Injection for use in patients for whom alternative treatment options [e.g., non-opioid analgesics or opioid combination products]: have not been tolerated, are not expected to be tolerated, have not provided adequate analgesia, or are not expected to provide adequate analgesia. To report SUSPECTED ADVERSE REACTIONS, contact Fresenius Kabi USA, LLC, at section on our website as well to find specific contact information and inquiry forms related to our products and services.  Thank you.  

KEY FACTS ABOUT FRESENIUS KABI USA, LLC

Company name
FRESENIUS KABI USA, LLC
Status
Active
Filed Number
M09000000890
FEI Number
300431740
Date of Incorporation
March 4, 2009
Age - 17 years
Home State
DE
Company Type
Foreign Limited Liability

CONTACTS

Website
http://freseniuskabiusa.com
Phones
(800) 551-7176
(847) 550-2300
(888) 391-6300

FRESENIUS KABI USA, LLC NEAR ME

Principal Address
Three Corporate Drive,
Lake Zurich,
IL,
60047,
US

See Also

Officers and Directors

The FRESENIUS KABI USA, LLC managed by the three persons and three company from Lake Zurich on following positions: Memb, Manager, Auth

Fresenius Kabi Pharmaceuticals Holdings, L

Position
Memb Active
Address
Three Corporate Drive, Lake Zurich, IL, 60047

John R Ducker

Position
Manager Active
From
Lake Zurich, IL, IL

Catherine Cappuzzello

Position
Auth Active
From
Lake Zurich, IL, IL





Registered Agent is CORPORATION SERVICE COMPANY

Address
1201 HAYS STREET, TALLAHASSEE, FL, 32301

Events

August 1, 2012
LC NAME CHANGE

Annual Reports

2025
January 25, 2025
2024
April 20, 2024